Kairos Pharma, Ltd. (NYSE American: KAPA) is a clinical stage company involved in treating EGFR-driven lung cancer patients with ENV105 in combination with osimertinib after they fail to respond ...

In the near term, the Company expects that the funded study may lead to more effective monitoring and early detection of resistance development, allowing for more timely interventions to improve ...

“It enables us to continue the development of our lead compound, as well as next-generation compounds.” “Adding Australia to our growing list of countries in which we have been granted patent ...

State Key Laboratory of Chemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China National Co-Innovation Center of Chemistry and Chemical ...

Researchers at Peking University have reported a major development in lead-free perovskite photovoltaics in a clear step ...